| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| 11 | 13 | 5 | 6 | 39 | 6 | 24 | 44 | |
Growth YoY Revenue Growth YoY% | 269.9 | -52.4 | 336.4 | 651.7 | ||||
| 7 | 6 | 4 | 6 | 12 | 6 | 4 | 26 | |
| 4 | 7 | 1 | 0 | 27 | 1 | 19 | 19 | |
OPM OPM% | 37.2 | 55.2 | 24.5 | -7.1 | 69.3 | 11.1 | 81.4 | 42.3 |
| 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
PBT PBTCr | 4 | 8 | 1 | 0 | 27 | 0 | 18 | 18 |
| 1 | 2 | 0 | -2 | 6 | 2 | 5 | 5 | |
| 3 | 5 | 1 | 2 | 20 | -2 | 13 | 13 | |
Growth YoY PAT Growth YoY% | 544.3 | -131.9 | 1,158.3 | 434.0 | ||||
NPM NPM% | 29.9 | 40.6 | 19.1 | 40.5 | 52.0 | -27.2 | 55.1 | 28.8 |
| 0.1 | 0.1 | 0.0 | 0.1 | 0.5 | 0.0 | 0.3 | 0.3 |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| 11 | 13 | 5 | 6 | 39 | 6 | 24 | 44 | |
Growth YoY Revenue Growth YoY% | 269.9 | -52.4 | 336.4 | 651.7 | ||||
| 7 | 6 | 4 | 6 | 12 | 6 | 4 | 26 | |
| 4 | 7 | 1 | 0 | 27 | 1 | 19 | 19 | |
OPM OPM% | 37.2 | 55.2 | 24.5 | -7.1 | 69.3 | 11.1 | 81.4 | 42.3 |
| 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
PBT PBTCr | 4 | 8 | 1 | 0 | 27 | 0 | 18 | 18 |
| 1 | 2 | 0 | -2 | 6 | 2 | 5 | 5 | |
| 3 | 5 | 1 | 2 | 20 | -2 | 13 | 13 | |
Growth YoY PAT Growth YoY% | 544.3 | -131.9 | 1,158.3 | 434.0 | ||||
NPM NPM% | 29.9 | 40.6 | 19.1 | 40.5 | 52.0 | -27.2 | 55.1 | 28.8 |
| 0.1 | 0.1 | 0.0 | 0.1 | 0.5 | 0.0 | 0.3 | 0.3 |
| Financial Year | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
Revenue RevenueCr | 33 | 57 | 113 |
Growth Revenue Growth% | 74.0 | 222.2 | |
| 20 | 28 | 48 | |
| 13 | 29 | 66 | |
OPM OPM% | 39.1 | 50.6 | 58.0 |
| 4 | 5 | 3 | |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 |
Depreciation DepreciationCr | 3 | 3 | 4 |
PBT PBTCr | 13 | 29 | 63 |
| 4 | 7 | 19 | |
PAT PATCr | 10 | 22 | 44 |
Growth PAT Growth% | 130.3 | 270.5 | |
NPM NPM% | 29.4 | 38.9 | 39.1 |
| 0.2 | 0.5 | 1.0 |
| Financial Year | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
Revenue RevenueCr | 33 | 57 | 113 |
Growth Revenue Growth% | 74.0 | 222.2 | |
| 20 | 28 | 48 | |
| 13 | 29 | 66 | |
OPM OPM% | 39.1 | 50.6 | 58.0 |
| 4 | 5 | 3 | |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 |
Depreciation DepreciationCr | 3 | 3 | 4 |
PBT PBTCr | 13 | 29 | 63 |
| 4 | 7 | 19 | |
PAT PATCr | 10 | 22 | 44 |
Growth PAT Growth% | 130.3 | 270.5 | |
NPM NPM% | 29.4 | 38.9 | 39.1 |
| 0.2 | 0.5 | 1.0 |
| Financial Year | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
Equity Capital Equity CapitalCr | 44 | 44 | 44 |
Reserves ReservesCr | 19 | 41 | 74 |
| 17 | 23 | 46 | |
| 7 | 5 | 11 | |
| 87 | 117 | 175 | |
| 65 | 84 | 128 | |
| 21 | 34 | 47 | |
| 87 | 117 | 175 |
| Financial Year | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
Equity Capital Equity CapitalCr | 44 | 44 | 44 |
Reserves ReservesCr | 19 | 41 | 74 |
| 17 | 23 | 46 | |
| 7 | 5 | 11 | |
| 87 | 117 | 175 | |
| 65 | 84 | 128 | |
| 21 | 34 | 47 | |
| 87 | 117 | 175 |
| Financial Year | Mar 2025 | Mar 2026 |
|---|---|---|
| 8 | 3 | |
| -1 | -14 | |
| -5 | 5 | |
Net Cash Flow Net Cash FlowCr | 2 | -6 |
Free Cash Flow Free Cash FlowCr | 5 | -13 |
CFO To PAT CFO To PAT% | 82.7 | 14.3 |
CFO To EBITDA CFO To EBITDA% | 62.2 | 11.0 |
| Financial Year | Mar 2025 | Mar 2026 |
|---|---|---|
| 8 | 3 | |
| -1 | -14 | |
| -5 | 5 | |
Net Cash Flow Net Cash FlowCr | 2 | -6 |
Free Cash Flow Free Cash FlowCr | 5 | -13 |
CFO To PAT CFO To PAT% | 82.7 | 14.3 |
CFO To EBITDA CFO To EBITDA% | 62.2 | 11.0 |
| Financial Year | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|
Market Cap Market CapitalizationCr | 957 | 1,329 | 3,724 |
Price To Earnings Price To Earnings | 99.3 | 60.7 | 82.5 |
Price To Sales Price To Sales | 29.4 | 23.4 | 32.9 |
Price To Book Price To Book | 15.2 | 15.7 | 29.8 |
EV To EBITDA EV To EBITDA | 74.5 | 46.2 | 56.9 |
GPM GPM% | 75.1 | 72.0 | 72.0 |
OPM OPM% | 39.1 | 50.6 | 58.0 |
NPM NPM% | 29.4 | 38.9 | 39.1 |
ROCE ROCE% | 20.8 | 33.4 | 45.7 |
ROE ROE% | 15.2 | 26.1 | 37.4 |
ROA ROA% | 11.0 | 18.8 | 25.3 |
| Financial Year | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|
Market Cap Market CapitalizationCr | 957 | 1,329 | 3,724 |
Price To Earnings Price To Earnings | 99.3 | 60.7 | 82.5 |
Price To Sales Price To Sales | 29.4 | 23.4 | 32.9 |
Price To Book Price To Book | 15.2 | 15.7 | 29.8 |
EV To EBITDA EV To EBITDA | 74.5 | 46.2 | 56.9 |
GPM GPM% | 75.1 | 72.0 | 72.0 |
OPM OPM% | 39.1 | 50.6 | 58.0 |
NPM NPM% | 29.4 | 38.9 | 39.1 |
ROCE ROCE% | 20.8 | 33.4 | 45.7 |
ROE ROE% | 15.2 | 26.1 | 37.4 |
ROA ROA% | 11.0 | 18.8 | 25.3 |
| Market CapitalizationMkt CapCr | 6,171 | 3,724 | 3,302 | 2,059 | 2,058 | 1,569 | 963 |
| Close PriceClose₹ | 190.16 | 84.16 | 468.95 | 21.90 | 335.95 | 1,110.15 | 817.60 |
| IndustryIndustry | Pharma Others | Pharma Others | Pharma Others | Pharma Others | Pharma Others | Pharma Others | Pharma Others |
| Price To EarningsPE | 3.77 | 82.51 | 9.74 | 21.68 | 111.61 | 5.67 | 19.57 |
| Price To SalesPS | 3.19 | 32.91 | 1.39 | 3.97 | 2.85 | 1.71 | 0.90 |
| RevenueRevenueCr | 1,932 | 113 | 2,369 | 518 | 721 | 918 | 1,068 |
| Revenue Growth TTMRev Gr TTM% | 3,141.0% | 222.2% | 6.4% | 0.6% | 19.4% | 11.3% | 42.7% |
| PAT Growth TTMPAT Gr TTM% | 712.6% | 270.5% | 283.1% | 51.6% | 323.7% | 317.3% | 16.8% |
| Market CapitalizationMkt CapCr | 6,171 | 3,724 | 3,302 | 2,059 | 2,058 | 1,569 | 963 |
| Close PriceClose₹ | 190.16 | 84.16 | 468.95 | 21.90 | 335.95 | 1,110.15 | 817.60 |
| IndustryIndustry | Pharma Others | Pharma Others | Pharma Others | Pharma Others | Pharma Others | Pharma Others | Pharma Others |
| Price To EarningsPE | 3.77 | 82.51 | 9.74 | 21.68 | 111.61 | 5.67 | 19.57 |
| Price To SalesPS | 3.19 | 32.91 | 1.39 | 3.97 | 2.85 | 1.71 | 0.90 |
| RevenueRevenueCr | 1,932 | 113 | 2,369 | 518 | 721 | 918 | 1,068 |
| Revenue Growth TTMRev Gr TTM% | 3,141.0% | 222.2% | 6.4% | 0.6% | 19.4% | 11.3% | 42.7% |
| PAT Growth TTMPAT Gr TTM% | 712.6% | 270.5% | 283.1% | 51.6% | 323.7% | 317.3% | 16.8% |